Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenikso Limited Regulatory News (FNK.PL)

Share Price Information for Fenikso Limited (FNK.PL)

Share Price is delayed by 15 minutes
Get Live Data
1.65    0.00 (0.00%)
Bid:
1.40
Ask:
1.90
Spread: 0.50 (35.714%)
Market Cap: £8.13m
FNK.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Fenikso Limited Share Chart

Partial Completion of Share Surrender

2 Aug 2023 17:36

RNS Number : 1257I
Fenikso Limited
02 August 2023
 

2 August 2023

Fenikso Limited

("Fenikso" or "the Company")  

Partial Completion of Share Surrender

Fenikso Limited (AQSE: FNK) (the "Company") announces that, further to its announcement of 4 January 2023 regarding the completion of the settlement deed dated 7 December 2022 entered into by, amongst others, the Company and Lekoil Nigeria Limited ("Lekoil Nigeraia") (the "Settlement Deed"), the surrender of 106,443,637 ordinary shares held by Lekoil Nigeria to the Company for nil consideration has now been completed. The Company has agreed to extend the period during which the remaining 1,215,210 ordinary shares (the "remaining shares") that are required to be surrendered by Lekoil Nigeria in accordance with the terms of the Settlement Deed until no later than 15 December 2023.

As at the date of this announcement, the Company's issued share capital consists of 492,952,784 ordinary shares with a nominal value of US$0.00005 each, with voting rights. The Company does not hold any shares in Treasury.

Therefore, the total number of Shares in the Company with voting rights is 492,952,784. This figure may be used by Shareholders in the Company as denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company under the Company's Memorandum and Articles of Association.

The Company shall issue a further announcement following the surrender of the remaining shares. 

For further information, please visit www.feniksoltd.com or contact:

First Sentinel Corporate Finance Ltd (AQSE Corporate Adviser)

Brian Stockbridge

 

+44 203 989 2200

Fenikso Limited

Thomas Richardson, Chairman

info@feniksoplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXNKBBNABKDPFK
Date   Source Headline
18th Jun 20267:00 amRNSAnnual results for the year ended 31 December 2025
13th May 20264:00 pmRNSReceipt of funds for repayment of US$51.9m loan
2nd Apr 20267:00 amRNSReceipt of funds for repayment of US$51.9m loan
6th Feb 202610:45 amRNSReceipt of funds for repayment of US$51.9m loan
31st Dec 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
31st Dec 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
24th Nov 20259:59 amRNSReceipt of funds for repayment of US$51.9m loan
5th Nov 20255:20 pmRNSTransaction In Own Shares
20th Oct 202512:58 pmRNSReceipt of funds for repayment of US$51.9m loan
6th Oct 20252:54 pmRNSTransaction In Own Shares
25th Sep 20254:01 pmRNSReceipt of funds for repayment of US$51.9m loan
25th Sep 20257:00 amRNSInterim Results
30th Jul 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
29th Jul 20251:09 pmRNSAGM Results
4th Jul 20257:00 amRNSNotice of AGM
18th Jun 20257:00 amRNSAnnual results for the year ended 31 December 2024
4th Jun 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
14th May 20257:00 amRNSTransaction In Own Shares
25th Apr 20258:57 amRNSRenegotiation of Savanah Investments Limited Loan
19th Mar 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
28th Feb 20255:32 pmRNSTransaction In Own Shares
31st Jan 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
12th Dec 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
6th Nov 20247:00 amRNSNotification of Investment
31st Oct 20241:28 pmRNSTR-1: Standard notification of major holdings
29th Oct 20245:32 pmRNSTransaction In Own Shares
28th Oct 20244:53 pmRNSTransaction In Own Shares
28th Oct 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
28th Oct 20247:00 amRNSShare Buyback Programme
30th Sep 20247:00 amRNSInterim Results
24th Sep 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
16th Aug 202410:29 amRNSNotification of First Investments
15th Aug 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
15th Aug 20247:00 amRNSResults of Annual General Meeting
12th Jul 20247:00 amRNSNotice of AGM
5th Jul 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
4th Jul 202410:35 amRNSTR-1: Standard notification of major holdings
27th Jun 20247:00 amRNSAnnual results for the year ended 31 December 2023
15th May 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
9th Apr 20249:25 amRNSReceipt of funds for repayment of US$51.9m loan
25th Jan 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
22nd Dec 20238:11 amRNSReceipt of funds for repayment of US$51.9m loan
28th Nov 20239:19 amRNSReceipt of funds for repayment of US$51.9m loan
30th Oct 20237:00 amRNSReceipt of funds for repayment of US$51.9m loan
26th Sep 20237:00 amRNSInterim Results
1st Sep 20231:29 pmRNSReceipt of funds for repayment of US$51.9m loan
2nd Aug 20235:36 pmRNSPartial Completion of Share Surrender
28th Jul 202312:09 pmRNSDirectorate Change
26th Jul 20235:06 pmRNSReceipt of funds for repayment of US$51.9m loan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.